Effects of everolimus plus minimized tacrolimus on kidney function in liver transplantation: REDUCE, a prospective, randomized controlled study.
Miguel Gómez-BravoMartín Prieto CastilloMiquel NavasaGloria Sánchez-AntolínLaura LladóAlejandra OteroTrinidad SerranoCarlos Jiménez RomeroMiguel García GonzálezAndrés ValdiviesoMaría Luisa González-DiéguezManuel de la MataJosé Antonio PonsMagdalena SalcedoJuan M RodrigoValentín Cuervas-MonsAntonio González RodríguezMireia CaraltFernando PardoEvaristo Varo PérezGonzalo CrespoÁngel RubinMagda GuileraAnna AldeaJulio SantoyoPublished in: Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva (2022)
EVR + rTAC allows a safe reduction in tacrolimus exposure in de novo liver transplant recipients, with a significant improvement in eGFR but without significant differences in renal clinical benefit 1 year after liver transplantation.